The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Other Relationship - HistoGeneX
MHCI and FOXP3 predicting outcome to neoadjuvant atezolizumab in sequential urothelial cancer tissue.
 
Bernadett Szabados
No Relationships to Disclose
 
Mark Kockx
No Relationships to Disclose
 
Pieter-Jan Van Dam
Other Relationship - HistoGeneX
 
Alejo Rodriguez-Vida
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Janssen; MSD; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; BMS Brazil; Janssen; MSD; Pfizer; Roche
Research Funding - MSD (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; BMS Brazil; Clovis Oncology; Ipsen; Janssen; Novartis
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche/Genentech
 
Simon J. Crabb
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Clovis Oncology; Janssen-Cilag; MSD; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Plexxikon
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen-Cilag; Roche
 
Michiel Simon Van Der Heijden
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); MSD Oncology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis; Roche
 
Albert Font
No Relationships to Disclose
 
Gwenaelle Gravis
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Aaron Prendergast
No Relationships to Disclose
 
Maurizio Perdicchio
Employment - F. Hoffmann LaRoche
 
Diana Stanoeva
Other Relationship - HistoGeneX
 
Sofie Daelemans
Other Relationship - HistoGeneX
 
Sanjeev Mariathasan
Employment - Genentech
 
Joy S. Tea
Employment - Genentech
 
Kelly Mousa
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Romain Banchereau
Employment - Genentech
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ferring; Gerson Lehrman Group; Janssen Research & Development; MERCK; Novartis; Pfizer; Roche/Genentech; Seattle Genetics/Astellas
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ferring; MSD; Novartis/Ipsen; Pfizer; Research to Practice; Roche/Genentech